SCHEMBL29673299

SCHEMBL29673299

O=C1CSc2cc(Br)ccc2CN1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CMA1 P23946 1/20 0.45
AHR P35869 1/20 0.45
PARP10 Q53GL7 2/20 0.39
TDP2 O95551 2/20 0.39
PARP1 P09874 1/20 0.39
MAOA P21397 3/20 0.38
MAOB P27338 3/20 0.38
HSD17B3 P37058 1/20 0.36
EPHX2 P34913 1/20 0.36
PARP11 Q9NR21 1/20 0.36
PNMT P11086 2/20 0.35
ASIC3 Q9UHC3 1/20 0.35
KCNN4 O15554 1/20 0.33
METAP1 P53582 1/20 0.33
HTT P42858 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9710025 0.80 PARP1 (0.39) PARP10TDP2PARP1MAOAMAOB
SCHEMBL30569562 0.76 HTT (0.56) TDP2PARP1MAOAMAOBEPHX2
SCHEMBL9710313 0.76 MAOB (0.61) MAOAMAOBHSD17B3METAP1HTT
SCHEMBL8526616 0.75 RYR2 (0.47) AHRMAOAMAOBHSD17B3EPHX2
SCHEMBL299571 0.74 MAOB (0.64) CMA1AHRMAOAMAOBEPHX2
SCHEMBL30199790 0.72 HTT (0.59) CMA1AHRMAOAMAOBEPHX2
SCHEMBL1332876 0.72 HTT (0.59) CMA1AHRMAOAMAOBEPHX2
SCHEMBL30040944 0.72 CMA1 (0.59) CMA1AHRPARP10TDP2PARP1
SCHEMBL1852665 0.72 CMA1 (0.59) CMA1AHRPARP10TDP2PARP1
SCHEMBL1948977 0.72 CMA1 (0.59) CMA1AHRPARP10TDP2PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4244213-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2023-09-20 EP disclosed
CN-116745288-A Compounds and uses thereof 福霍恩治疗公司 2023-09-12 CN disclosed
WO-2022103899-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2022-05-19 WO disclosed